SCHEMBL23964441

SCHEMBL23964441

CCCC(C)(CC)c1ncccc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 7/20 0.37
KMT2A Q03164 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
COMT P21964 2/20 0.36
CHRM1 P11229 2/20 0.34
MMP2 P08253 1/20 0.34
TSHR P16473 1/20 0.34
ADRA1A P35348 1/20 0.34
METAP2 P50579 1/20 0.34
METAP1 P53582 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34
HSD17B10 Q99714 3/20 0.33
HPGD P15428 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23419232 0.78 SSTR4 (0.41) GAA
SCHEMBL31505059 0.74 KDM4E (0.50) ALDH1A1L3MBTL1KDM4EKMT2ACOMT
SCHEMBL2627824 0.74 KDM4E (0.50) ALDH1A1L3MBTL1KDM4EKMT2ACOMT
SCHEMBL5038676 0.72 ALDH1A1 (0.44) ALDH1A1L3MBTL1KDM4EKMT2ACOMT
SCHEMBL15979318 0.72 ESR1 (0.32) ESR1ESR2TLR8
SCHEMBL22140286 0.71 P2RX7 (0.33) KDM4EESR1ESR2COMTGAA
SCHEMBL24759749 0.71 CYP3A4 (0.51) ALDH1A1TSHRMAPTNPC1
SCHEMBL1331870 0.71 KDM4E (0.43) ALDH1A1L3MBTL1KDM4EKMT2ACOMT
SCHEMBL755065 0.71 KDM4E (0.43) ALDH1A1L3MBTL1KDM4EKMT2ACOMT
SCHEMBL29834150 0.71 KDM4E (0.43) ALDH1A1L3MBTL1KDM4EKMT2ACOMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155547-B1 Compounds for and methods of treating diseases Alterity Therapeutics Limited (AU) 2021-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11155547-B1 Compounds for and methods of treating diseases HTT, SNCA, PARK7 ALDH1A1 2721/4885L3MBTL1 2678/4885KDM4E 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.